Landmark Study Shows GeneSight Test Led to Significant Improvement in Mental Health Outcomes for Patients with Major Depressive Disorder Genetics Investing
Krystal Biotech Announces FDA Clearance of IND on KB103 to Begin Enrolling Patients for the Treatment of Dystrophic Epidermolysis Bullosa Genetics Investing
U.S. FDA Clears Pluristem’s Phase III Study in Treatment of Muscle Injury Following Hip Fracture Surgery Genetics Investing
AveXis Presents Initial Data from Pivotal U.S. Trial for SMA Type 1 and 24-Month Follow-Up Data Genetics Investing
Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina Lineberger Advanced Cellular Therapeutics Facility for X-Series Pharmaceutical Investing
Precision Therapeutics Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares Pharmaceutical Investing
UTHealth in Houston and Athersys Announce Funding for Clinical Trial using MultiStem® to Treat Trauma Patients Genetics Investing
Cynata Therapeutics Completes Patent Application to Cover Cymerus Stem Cell Technology Genetics Investing
OpGen Completes Rapid Testing Clinical Trial in Colombia and Expands International Operations Genetics Investing
